Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.
暂无分享,去创建一个
R J Hodgkiss | A. J. van der Kogel | J. Raleigh | P. Rijken | P F Rijken | H J Bernsen | A J van der Kogel | J A Raleigh | R. Hodgkiss | J P Peters | J. Peters | H. Bernsen | A. Kogel | P.F.J.W. Rijken | H. J. J. A. Bernsen
[1] M. Horsman,et al. Tumor blood flow changes induced by chemical modifiers of radiation response. , 1992, International journal of radiation oncology, biology, physics.
[2] P. Wesseling,et al. Hypoxia in a human intracerebral glioma model. , 2000, Journal of neurosurgery.
[3] J. Bussink,et al. Changes in Blood Perfusion and Hypoxia after Irradiation of a Human Squamous Cell Carcinoma Xenograft Tumor Line , 2000, Radiation research.
[4] B Vojnovic,et al. Measurement of oxygen tension in tumours by time-resolved fluorescence. , 1996, The British journal of cancer. Supplement.
[5] J. A. van der Laak,et al. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. , 1997, British Journal of Cancer.
[6] A. Heerschap,et al. In vivo (31)P magnetic resonance spectroscopy and morphometric analysis of the perfused vascular architecture of human glioma xenografts in nude mice. , 1997, British Journal of Cancer.
[7] S. Rockwell,et al. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.
[8] J. Bussink,et al. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts. , 1998, British Journal of Cancer.
[9] H. Awwad,et al. Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. , 1986, International journal of radiation oncology, biology, physics.
[10] A S Kennedy,et al. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. , 1998, Gynecologic oncology.
[11] M. Trotter,et al. The use of fluorescent probes to identify regions of transient perfusion in murine tumors. , 1989, International journal of radiation oncology, biology, physics.
[12] M. Dewhirst,et al. Microvascular studies on the origins of perfusion-limited hypoxia. , 1996, The British journal of cancer. Supplement.
[13] S M Evans,et al. Interlaboratory variation in oxygen tension measurement by Eppendorf “Histograph” and comparison with hypoxic marker , 1997, Journal of surgical oncology.
[14] C. J. Koch,et al. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. , 1987, British Journal of Cancer.
[15] D. Ruiter,et al. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. , 1995, The American journal of pathology.
[16] M. Varia,et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. , 1997, International journal of radiation oncology, biology, physics.
[17] O. S. Nielsen,et al. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. , 1996, International journal of radiation oncology, biology, physics.
[18] J. Raleigh,et al. Identification of nonproliferating but viable hypoxic tumor cells in vivo. , 1998, Cancer research.
[19] J. Overgaard,et al. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing. , 1994, Acta oncologica.
[20] T. Oostendorp,et al. Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. , 1995, British Journal of Cancer.
[21] J. Dunn,et al. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study. , 1996, Cancer research.
[22] K. Groebe,et al. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids , 1995, International journal of cancer.
[23] A. J. van der Kogel,et al. Delayed vascular changes after antiangiogenic therapy with antivascular endothelial growth factor antibodies in human glioma xenografts in nude mice. , 1998, Neurosurgery.
[24] R. J. Hodgkiss,et al. Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy. , 1996, British Journal of Cancer.
[25] R. Hill,et al. Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 Histograph, [3H]misonidazole binding and paired survival assay. , 1996, Radiation research.
[26] P Vaupel,et al. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.
[27] C. Koch,et al. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. , 1995, British Journal of Cancer.
[28] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[29] R. Thomlinson. Changes of Oxygenation in Tumours in Relation to Irradiation , 1969 .
[30] P Vaupel,et al. Oxygenation of human tumors. , 1990, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[31] S M Evans,et al. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. , 2000, Cancer research.
[32] R J Hodgkiss,et al. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours. , 1995, Cytometry.
[33] B. Fenton,et al. Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements , 1999, British Journal of Cancer.
[34] M C Weissler,et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. , 1998, Cancer research.
[35] J M Brown,et al. Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. , 1979, The British journal of radiology.
[36] A. W. Simonetti,et al. Characterization and validation of noninvasive oxygen tension measurements in human glioma xenografts by 19F-MR relaxometry. , 1999, International journal of radiation oncology, biology, physics.
[37] D. Thrall,et al. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. , 1997, Radiation research.
[38] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[39] D. Thrall,et al. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors. , 1995, Acta oncologica.
[40] G. Hanks,et al. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[41] M. Parliament,et al. Imaging tumor hypoxia and tumor perfusion. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[42] G. Rosner,et al. Distribution of the hypoxia marker CCI-103F in canine tumors. , 1994, International journal of radiation oncology, biology, physics.
[43] A. J. van der Kogel,et al. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. , 1995, Microvascular research.
[44] C. Koch,et al. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. , 1996, The Journal of pharmacology and experimental therapeutics.
[45] D. Chaplin,et al. Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[46] A Heerschap,et al. Noninvasive Assessment of the Functional Neovasculature in 9L-Glioma Growing in Rat Brain by Dynamic 1H Magnetic Resonance Imaging of Gadolinium Uptake , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[47] G. Arteel,et al. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. , 1995, British Journal of Cancer.
[48] S. Rockwell,et al. Hypoxic fractions of human tumors xenografted into mice: a review. , 1990, International journal of radiation oncology, biology, physics.
[49] P. Olive. Radiation-induced reoxygenation in the SCCVII murine tumour: evidence for a decrease in oxygen consumption and an increase in tumour perfusion. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[50] P. Wardman,et al. The measurement of hypoxia in tumours. , 1992, BJR supplement.
[51] J F Gross,et al. Analysis of oxygen transport to tumor tissue by microvascular networks. , 1993, International journal of radiation oncology, biology, physics.
[52] R J Hodgkiss,et al. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[53] G. Wilson,et al. Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. , 1991, British Journal of Cancer.
[54] V. Bertone,et al. Characterization of the metabolism of perinecrotic cells in solid tumors by enzyme histochemistry. , 1996, Anticancer research.